Richard Furie, MD

Richard Furie, MD, is Chief of the Division of Rheumatology at Northwell Health.

Articles by Richard Furie, MD

Insights: Obinutuzumab Faces Integration Challenges, Long-Term Potential in Lupus Nephritis

ByLuke Halpern, Associate Editor,Richard Furie, MD

March 11th 2025

Expert: Obinutuzumab Shows Promise in Lupus Nephritis, Reinforcing Role in High-Disease Patients

ByLuke Halpern, Associate Editor,Richard Furie, MD

March 4th 2025

Obinutuzumab is effective in reducing proteinuria and preserving kidney function in lupus nephritis, with consistent benefits across high-disease activity subgroups.

Richard Furie, MD

Articles by Richard Furie, MD

Insights: Obinutuzumab Faces Integration Challenges, Long-Term Potential in Lupus Nephritis

Expert: Obinutuzumab Shows Promise in Lupus Nephritis, Reinforcing Role in High-Disease Patients

Latest Updated Articles

Trending on Pharmacy Times

TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs

Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment

SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury

Evaluating Pharmacists’ Role In Veterinary Medication Management and Education

Enlicitide Meaningfully Lowers LDL-C at 24 Weeks in Patients At Risk for ASCVD Events